Benitec Biopharma IncNASDAQ:BNTC
- LAST PRICE10.4500
- TODAY'S CHANGE (%)-0.3500 (-3.2407%)
- Bid / Lots10.3000/ 5
- Ask / Lots10.5000/ 5
- Open / Previous Close10.7000 / 10.8000
- Day Range
- 52 Week Range
- Volume22,510
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BNTC |
|---|---|---|
| 09:32 ET | 954 | 10.7 |
| 10:18 ET | 100 | 10.75 |
| 11:20 ET | 100 | 10.75 |
| 12:26 ET | 277 | 10.5875 |
| 12:30 ET | 100 | 10.5892 |
| 12:35 ET | 510 | 10.8 |
| 12:37 ET | 216 | 10.69 |
| 12:44 ET | 200 | 10.55 |
| 01:47 ET | 100 | 10.56 |
| 01:49 ET | 1100 | 10.56 |
| 02:25 ET | 1500 | 10.5 |
| 02:32 ET | 100 | 10.5 |
| 02:38 ET | 100 | 10.5 |
| 03:21 ET | 100 | 10.5 |
| 03:30 ET | 300 | 10.55 |
| 03:33 ET | 3512 | 10.45 |
| 03:35 ET | 500 | 10.45 |
| 03:37 ET | 865 | 10.49 |
| 03:39 ET | 636 | 10.48 |
| 03:42 ET | 600 | 10.45 |
Yesterday
Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
8:00AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 16, 2024
DJ Benitec Biopharma Initiated at Outperform by Oppenheimer, from 5:22AM ET on Wednesday Oct 16, 2024 by Dow Jones
5:22AM ET on Wednesday Oct 16, 2024 by Dow Jones
Oct 14, 2024
DJ Benitec Biopharma Is Maintained at Market Outperform by JMP Securities, from 7:34AM ET on Monday Oct 14, 2024 by Dow Jones
7:34AM ET on Monday Oct 14, 2024 by Dow JonesBenitec Biopharma Announces Updated Investor Webcast Information, from 6:00AM ET on Monday Oct 14, 2024 by Dow Jones
6:00AM ET on Monday Oct 14, 2024 by Dow Jones
Oct 12, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Benitec Biopharma Inc | 214.0M | -1.4x | --- |
Onkure Therapeutics Inc | 217.7M | -1.0x | --- |
Solid Biosciences Inc | 218.4M | -1.8x | --- |
Corbus Pharmaceuticals Holdings Inc | 220.5M | -3.3x | --- |
Trevi Therapeutics Inc | 220.7M | -7.8x | --- |
PepGen Inc | 221.3M | -2.1x | --- |
Company Information
Benitec Biopharma Inc is a clinical-stage biotechnology company. The Company is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.
Contact Information
- Headquarters
- 3940 Trust WayHAYWARD, CA, United States 94545
- Phone
- 510-780-0819
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board, Chief Executive Officer
- Jerel Banks
- Executive Director
- Megan Boston
- Independent Director
- J. Kevin Buchi
- Independent Director
- Peter Francis
- Independent Director
- Kishan Mehta
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $214.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 19.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-7.63 |
Book Value | $4.68 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
